No Data
No Data
Friedreich's Ataxia Market to Grow at a Substantial Growth Rate by 2034, Examines DelveInsight | Key Companies - Retrotope, PTC Therapeutics, Minoryx Therapeutics, Biogen, Lexeo Therapeutics, Larimar Therapeutics
New York, USA, July 16, 2024 (GLOBE NEWSWIRE) -- Friedreich's Ataxia Market to Grow at a Substantial Growth Rate by 2034, Examines DelveInsight | Key Companies - Retrotope, PTC Therapeutics, Minoryx
Express News | Cantor Fitzgerald Reiterates Overweight on PTC Therapeutics, Maintains $62 Price Target
Lexeo Stock Drops 24% Amid Friedreich Ataxia Study Results
PTC Therapeutics Is Maintained at Equal-Weight by Morgan Stanley
PTC Therapeutics Is Maintained at Equal-Weight by Morgan
PTC Therapeutics Price Target Raised to $32.00/Share From $30.00 by Morgan Stanley
PTC Therapeutics Price Target Raised to $32.00/Share From $30.00 by Morgan
Morgan Stanley Sticks to Their Hold Rating for PTC Therapeutics (PTCT)
No Data
The Real Wojak : Do you have like a top 3-5 that you like more than all the other ones? This list is way too long
72991267 : Glad I have some $Candel Therapeutics (CADL.US)$ after my disastrous SBFM.
Rana Hasan1 : List too long